Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07158736 · ClinicalTrials.gov registry record · NA

Genicular Nerve Block for Knee Pain in the ED

A NA study of Knee Pain, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
34
Enrollment target
4
Study locations

NCT07158736 is a NA study of Knee Pain that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 34 participants. The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07158736, a NA study of Knee Pain, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
34 participants
Enrollment target
4
Study locations

Study Summary

Patient with atraumatic knee pain without a large knee effusion on x-ray will be randomized to receive either a genicular nerve block (GNB) or standard of care in the emergency department.

Conditions Studied

Interventions

  • OTHER Standard of Care
  • PROCEDURE Genicular nerve block with bupivacaine and corticosteroids

Study Locations (4)

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia
  • Pennsylvania Hospital - Philadelphia
  • Pennsylvania Presbyterian Medical Center - Philadelphia
  • HUP Cedar - Philadelphia

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2025-08-06
Est. Completion 2026-09-01
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT07158736

The ClinicalTrials.gov registry entry for NCT07158736 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Knee Pain appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT07158736 reports 4 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07158736 about?

NCT07158736 is a clinical study titled "Genicular Nerve Block for Knee Pain in the ED". Patient with atraumatic knee pain without a large knee effusion on x-ray will be randomized to receive either a genicular nerve block (GNB) or standard of care in the emergency department.

What is the current status of trial NCT07158736?

This trial is currently recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2025-08-06. Estimated completion is 2026-09-01.

What conditions does trial NCT07158736 study?

This clinical trial studies the following conditions: Knee Pain.

What interventions are being tested in trial NCT07158736?

The interventions under investigation include: Standard of Care (OTHER), Genicular nerve block with bupivacaine and corticosteroids (PROCEDURE).

Who is sponsoring clinical trial NCT07158736?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07158736 being conducted?

This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.